NasdaqGS - Nasdaq Real Time Price USD
Ascendis Pharma A/S (ASND)
As of 1:18 PM EST. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
27.5
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
NTLA Intellia Therapeutics, Inc. | 27 | -- | -- | -- |
AURA Aura Biosciences, Inc. | 27 | -- | -- | -- |
ASND Ascendis Pharma A/S | 27 | -- | -- | -- |
NUVL Nuvalent, Inc. | 27 | -- | -- | -- |
SNPHF Santen Pharmaceutical Co., Ltd. | 27 | 3 | 16 | 9 |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 11/2024
ASND
Category Average
1 Low Controversy Level
None 4 Severe
1.0 ASND
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
PCVX Vaxcyte, Inc.
91.63
+6.59%
NAMS NewAmsterdam Pharma Company N.V.
20.35
+1.70%
ARGX argenx SE
586.70
-0.87%
PTGX Protagonist Therapeutics, Inc.
42.66
+4.95%
CYTK Cytokinetics, Incorporated
48.94
-1.85%
SWTX SpringWorks Therapeutics, Inc.
37.26
-0.49%
BBIO BridgeBio Pharma, Inc.
23.50
+1.97%
INSM Insmed Incorporated
73.06
+0.54%
LEGN Legend Biotech Corporation
39.75
-0.98%
ACLX Arcellx, Inc.
88.65
+1.64%